1 Product identity
Ingredient risk
1 ingredient to use with caution

PRO-Glucose Balance

BrandHyperbioticsOther Combinations Tablet or Pill 22 ingredients 1 caution DSLD #328432
Net contents: 60 Time-Release Tablet(s)
Target: Adults and Children 4 years and above
DSLD entry: 2025-05-21
2 Ingredients (22)
IngredientGroupSafety
Total CarbohydratesCarbohydrate
Dietary FiberFiber (unspecified)
Total SugarsSugar
Added SugarsSugar
Vitamin DVitamin DUse with Caution
SodiumSodiumConditionally Safe
Proprietary Probiotic BlendProprietary Blend
L. fermentumLactobacillus fermentum
L. plantarumLactobacillus plantarum
B. longum infantisBifidobacterium infantis
B. animalis lactisBifidobacterium animalis lactis
L. acidophilusLactobacillus acidophilus
L. caseiLactobacillus casei
L. reuteriLactobacillus reuteri
Banaba leaf extractbanaba
Microcrystalline CelluloseCellulose
HydroxypropylmethylcelluloseHydroxypropyl cellulose
PectinPectin
Sodium CarbonateSodiumConditionally Safe
Stearic AcidStearic Acid
Guar GumGuar
TurmericTurmericConditionally Safe
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
⚠️ Use with caution — restricted in some markets
Vitamin D — Granulomatous diseases (sarcoidosis, TB) — unregulated extra-renal CYP27B1 can cause life-threatening hypercalcemia even at standard doses [2][21]
3 Safety cross-reference
Vitamin D — Use with Caution
⚠ Hypercalcemia at >10,000 IU/day
⚠ Vascular calcification risk
Sodium — Conditionally Safe
⚠ Hypertension
⚠ Fluid retention
4 Label claims
• Nutrient
• All Other
• Structure/Function
5 Data source
DSLD ID328432
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2025-05-21
6 More from Hyperbiotics
View Hyperbiotics Safety Scorecard → 3 products
PrebioticPRO-Women
7 Cite this page
Vancouver
Pkhakadze G. PRO-Glucose Balance — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Aug 30]. Available from: https://supplement.ge/products/pro-glucose-balance-328432/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG
© 2026 supplement.ge · PHIG · Sheni Network